Extracellular Vesicles (EVs) & Lipid Nanoparticles (LNPs) 2025

SelectBIO Extracellular Vesicles (EVs) and Lipid Nanoparticles (LNPs) 2025 conference brings together researchers and industry participants from both academia and companies focusing on studying the biology of EVs and LNPs and focusing on the interface of these fields.

Presentations will explore the latest advances in the EVs field, from the study of their biology to their potential as engineered drug delivery vehicles and therapeutics (targeted delivery of biologics and small molecules).

Additionally, the use of LNPs – already successfully deployed in the clinic as the Covid-19 vaccine – as a platform for vaccine and therapy deployment will be the focus of this conference and companies developing LNPs present their research and frame it in the context of clinical utility.